
Develops dynamically steerable 0.014" guidewires and access systems for neurovascular interventions.

Artiria Medical SA
Geneva (Campus Biotech) · Canton de VaudNew on Amplifa
About Artiria Medical
Artiria Medical SA is a Swiss medical technology company founded in 2019, headquartered at Campus Biotech in Geneva. The company develops and manufactures (micro-)guidewires and access systems for neurovascular interventions, in particular for the treatment of hemorrhagic and ischemic strokes as well as brain aneurysms. The core product SmartGUIDE™ 014 is a dynamically steerable 0.014" guidewire featuring in-situ tip deflection, hydrophilic coating, constant torque transmission and intuitive one-handed control via a pusher button. The solution replaces the time-consuming manual shaping of the tip outside the patient and enables precise navigation in complex, tortuous vascular anatomies. SmartGUIDE™ 014 is FDA-cleared and CE-marked and is commercially marketed in the USA and Europe. Artiria Medical is ISO 13485 certified and has been supported by Innosuisse, Venture Kick, FIT, the Gebert Rüf Foundation, EPFL, the Wyss Center and SERI.
- Site
- Geneva
- Processes
- Development and manufacturing of (micro-)guidewires and access systems for neurovascular, SmartGUIDE™ 014: dynamically steerable 0.014" guidewire with in-situ tip deflection, Regulatory approval: FDA-cleared and CE-marked
- Materials
- SmartGUIDE™ 014 Guidewire Technology, Hydrophilic Coating
- Certificates
- ISO 13485
- Founded
- 2019
- Employees
- 2-10
- Industries
- Medical technology / Medical devices (manufacturing), Neurovascular endovascular surgery / interventional neuroradiology, Stroke treatment (hemorrhagic and ischemic strokes), brain aneurysms
- 01
R&D and development
- 02
Regulatory approval (FDA, CE)
- 03
Manufacturing of guidewires and access systems
- 04
Distribution in the USA and Europe
- 05
Clinical use and training
Technology & Processes
SmartGUIDE™ 014 Guidewire Technology
0.014 inch x 200 cm guidewire with soft atraumatic tip, dynamic tip deflection and incremental angle locking.
Hydrophilic Coating
Market-recognized first-class hydrophilic coating for smooth intravascular navigation.
Locations
Geneva (Campus Biotech)
CHOffice & Lab
Products & Components

Inside the production
Industries
Additional services
Reference customers
Quality & Certification
Artiria Medical is an ISO 13485 certified company. The products are FDA-cleared and CE-marked.
| Evidence | Geneva (Campus Biotech) |
|---|---|
| ISO 13485 |
History
- 2019
Founding of Artiria Medical
- 2023
Received the Innosuisse Certificate
- 2023
Admission to the 'Scale up coaching' phase of the Innosuisse program after successfully completing Phases 1 and 2
- 2024
Financing: USD 6 million secured to advance the stroke technology in Europe and the USA; support from FIT, Gebert Rüf Foundation, EPFL, Innosuisse, Venture Kick, Wyss Center, SERI; winner of the IMD Startup Competition
- 2025/2026
First-in-Human study with SmartGUIDE completed and published in Neuroradiology; first treatments of unruptured brain aneurysms at the HUG
- 2026
SmartGUIDE™ 014 FDA-cleared and CE-marked; market launch in the USA and Europe; participation in ESMINT congresses (including Marseille)